Dr. Brian F. Canavan, DO

Dr. Canavan practices at Astera Cancer Care - East Brunswick in East Brunswick, New Jersey.

Dr. Canavan's NPI, 1760595516, was assigned on August 16, 2006. Dr. Canavan graduated from Des Moines University in 1989. Dr. Canavan holds New Jersey license 25MB05551400.

Dr. Canavan's primary practice is Astera Cancer Care - East Brunswick, at 629 Cranbury Rd, East Brunswick, NJ 08816 in Middlesex County. The practice phone is (732) 390-7750.

Dr. Canavan's primary practice is Astera Cancer Care - East Brunswick in East Brunswick, New Jersey. Dr. Canavan is also affiliated with Jersey Shore University Medical Center. The medical group on file is Astera Cancer Care. Dmand AI also links Dr. Canavan to 4 more hospitals, 2 group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Canavan practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Canavan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Canavan is board certified in hematology by the AOA Board of Internal Medicine. Dr. Canavan is licensed in New Jersey.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Canavan treats.

CMS data shows 64,811 Medicare services from Dr. Canavan across 35 procedure codes in 2024, for 875 Medicare patients. Medicare paid $679,815 for them.

CMS counts 875 Medicare patients who saw Dr. Canavan in 2024. The largest group is 65 to 74, with 335 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Canavan's median patient age at 71, with 57% women.

In 2024, Dr. Canavan wrote 2,362 Medicare Part D claims for 392 patients. 58% of them were for generic drugs. CMS names the drug for 1,981 of them, across 51 drugs with 11 or more claims each, at $4,910,660 in total drug cost. In 2023, CMS named 1,840 claims across 53 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Canavan for performance year 2024, reported as part of a group. Dr. Canavan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Canavan as offering telehealth.

Dmand AI links 4 papers to Dr. Canavan, published from 2016 to 2023. Dr. Canavan has published most often in Ir Med J.

CMS Open Payments shows 323 general payments to Dr. Canavan from 66 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Bristol-Myers Squibb Company paid the most, $397.

Dmand AI lists 1 award for Dr. Canavan, most recently CMS Stage 1 EHR in 2013.

Dr. Canavan graduated from Des Moines University in 1989. Dr. Canavan is a member of AOA and ASCO.

Dr. Canavan is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Horizon Blue Cross Blue Shield of New Jersey. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.